Drug companies cut HIV drug prices in the developing world
نویسندگان
چکیده
منابع مشابه
Drug companies should cut prices for developing countries, says G8 report.
international guidelines on health research. ''In the absence of such committees , it becomes difficult for countries to uphold and enforce research ethics, either for their home researchers or outsiders,'' said Leke. ''This forum will ensure that African countries establish competent ethic committees capable of facing the challenges of our times''. She added that health researchers needed rigo...
متن کاملCompanies reduce prices for HIV drugs in developing countries.
This article reports the decision of pharmaceutical companies to reduce the prices of anti-HIV drugs in developing countries. It is stated that some of the companies have pledged to sell the pharmaceuticals at prices just above the manufacturing costs, at a discount of up to 90%. This strategy is part of an unprecedented effort to combat AIDS in sub-Saharan Africa. Participating companies in...
متن کاملTreating HIV in the developing world: getting ahead of the drug development curve.
At the 2006 International AIDS Conference (http://www.aids2006.org/), an impressive range of new therapeutic developments for HIV/AIDS were described. Several new drugs, and new drug classes (entry and fusion inhibitors, integrase inhibitors, and maturation antagonists) are offering great hope for more effective treatment [1]. At the same time, however, the conference also saw unrest among trea...
متن کاملImproving drug use for children in the developing world.
Children differ significantly from adults in the way they absorb, metabolise, and excrete drugs. These parameters also vary as children grow from neonates through to adolescence. The practical implications and challenges that this presents are well know to anyone who is involved in the medical management of sick children. The importance of paediatric medication safety and efficacy has been gain...
متن کاملAntiretroviral (ARV) drug resistance in the developing world.
OBJECTIVES To describe the overall prevalence of ARV resistance in the developing world, focusing on: (1) treatment naïve populations, (2) the resistance consequences of prevention of mother to child transmission (pMTCT) drug regimens, and (3) the relationship of medication adherence to resistance. DATA SOURCES We searched PubMed(R), EMBASE, the Cochrane Controlled Clinical Trials Register Da...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2000
ISSN: 0959-8138
DOI: 10.1136/bmj.320.7246.1357